Catalyst Wire Dossier Catalyst Wire Dossier

Abiraterone Acetate Plus Prednisone

abiraterone acetate · Janssen Research & Development, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abiraterone Acetate Plus Prednisone, covering 2020-01-21 to 2020-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer [Phase 3]

See pricing